BSE - Free Realtime Quote • INR
Biocon Limited (BIOCON.BO)
As of 11:51 AM GMT+5:30. Market Open.
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
140,445,000.00
109,341,000.00
80,248,000.00
70,074,000.00
Cost of Revenue
48,009,000.00
36,668,000.00
27,236,000.00
22,454,000.00
Gross Profit
92,436,000.00
72,673,000.00
53,012,000.00
47,620,000.00
Operating Expense
69,935,000.00
58,535,000.00
42,333,000.00
41,571,000.00
Operating Income
22,501,000.00
14,138,000.00
10,679,000.00
6,049,000.00
Net Non Operating Interest Income Expense
-8,838,000.00
-3,066,000.00
445,000.00
193,000.00
Pretax Income
17,028,000.00
8,971,000.00
9,831,000.00
10,677,000.00
Tax Provision
2,134,000.00
2,541,000.00
2,115,000.00
2,215,000.00
Net Income Common Stockholders
12,002,000.00
4,627,000.00
6,484,000.00
7,405,000.00
Diluted NI Available to Com Stockholders
12,002,000.00
4,627,000.00
6,484,000.00
7,405,000.00
Basic EPS
10.05
3.88
5.44
6.24
Diluted EPS
10.03
3.87
5.42
6.19
Basic Average Shares
1,192,659.29
1,193,095.95
1,191,074.68
1,187,130.76
Diluted Average Shares
1,196,698.87
1,195,925.59
1,196,351.67
1,196,760.91
Rent Expense Supplemental
--
29,000.00
38,000.00
58,000.00
Total Expenses
117,944,000.00
95,203,000.00
69,569,000.00
64,025,000.00
Net Income from Continuing & Discontinued Operation
12,002,000.00
4,627,000.00
6,484,000.00
7,405,000.00
Normalized Income
10,376,850.13
5,475,300.00
7,260,880.00
6,008,200.00
Interest Income
--
1,124,000.00
1,121,000.00
770,000.00
Interest Expense
9,962,000.00
4,190,000.00
676,000.00
577,000.00
Net Interest Income
-8,838,000.00
-3,066,000.00
445,000.00
193,000.00
EBIT
26,990,000.00
13,161,000.00
10,507,000.00
11,254,000.00
EBITDA
42,245,000.00
24,292,000.00
18,649,000.00
18,405,000.00
Reconciled Cost of Revenue
48,009,000.00
36,668,000.00
27,236,000.00
22,454,000.00
Reconciled Depreciation
15,255,000.00
11,131,000.00
8,142,000.00
7,151,000.00
Net Income from Continuing Operation Net Minority Interest
12,002,000.00
4,627,000.00
6,484,000.00
7,405,000.00
Total Unusual Items Excluding Goodwill
1,858,000.00
-998,000.00
-996,000.00
1,746,000.00
Total Unusual Items
1,858,000.00
-998,000.00
-996,000.00
1,746,000.00
Normalized EBITDA
40,387,000.00
25,290,000.00
19,645,000.00
16,659,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
232,850.13
-149,700.00
-219,120.00
349,200.00
3/31/2021 - 4/7/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade